
About Multani Pharmaceutical
Multani Pharmaceutical was a Healthcare company based in Delhi (India) founded in 1983. Manufacturer of ayurvedic herbal medicines. It operates on a Alternative Medicine Products model. The company has 483 employees. Its Indian entity Multani Pharmaceuticals Limited reported revenue of βΉ274 Cr. The company is recorded as dissolved. Multani Pharmaceutical offers products and services including Multani Pharmaceutical Platform. Its focus areas include Alternative Medicine Products.
Company details
Multani Pharmaceutical manufacturer of ayurvedic herbal medicines through providing healthcare solutions, alternative medicine products, alternative medicine products, and providing healthcare solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Delhi, India
- Employees 483
- SectorsHealthcare
- Website multaniayurved.org
- Legal Name Multani Pharmaceuticals Limited
- Date of Incorporation 05 Mar, 1986
- Jurisdiction Delhi, India
- Annual Revenue₹274 Cr
FY 2025 · +2% YoY
- Net Profit₹28.22 Cr
FY 2025 · 10% margin
- EBITDA₹44.29 Cr
FY 2025 · 16% margin
- Employee Count483
Associated legal entities of Multani Pharmaceutical
Multani Pharmaceutical operates through Multani Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Multani Pharmaceuticals Limited CIN U24230DL1986PLC023539 | Active | 05 Mar 1986 | New Delhi, Delhi | ₹274 Cr | 483 | 5 | View details |
Products & Services of Multani Pharmaceutical
Multani Pharmaceutical offers a comprehensive portfolio of products and services, including Multani Pharmaceutical Platform.
Manufacturer of ayurvedic & herbal medicines
Board of directors of Multani Pharmaceuticals Limited (Multani Pharmaceutical)
Multani Pharmaceuticals Limited is the primary company behind Multani Pharmaceutical. The board of Multani Pharmaceuticals Limited currently have 5 directors; the longest-serving is Pradeep Multani, appointed in 1986. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pradeep Multani DIN 00109071 | Director | 08 Mar 1986 | 40 yrs 8 mo | Multani Pharmaceuticals Limited |
| Rajesh Sabharwal DIN 00636236 | Director | 27 Feb 2019 | 7 yrs 8 mo | Multani Pharmaceuticals Limited |
| Yogesh Sahni DIN 00811667 | Director | 27 Feb 2019 | 7 yrs 8 mo | Multani Pharmaceuticals Limited |
| Sanjay Kumar DIN 09271907 | Director | 01 Feb 2023 | 3 yrs 9 mo | Multani Pharmaceuticals Limited |
| Vinay Rungta DIN 09846999 | Director | 01 Feb 2023 | 3 yrs 9 mo | Multani Pharmaceuticals Limited |
Financials of Multani Pharmaceutical
Figures of Multani Pharmaceuticals Limited, the primary company behind Multani Pharmaceutical, for FY 2025. Revenue was ₹274 Cr (+2% year on year). Net profit was ₹28.22 Cr (10% margin). EBITDA was ₹44.29 Cr (16% margin). Revenue has grown at a compounded annual rate of +10% over three years and +13% over five years.
- ₹274 CrRevenue · FY 2025 · +2% YoY
- ₹28.22 CrNet profit · 10% margin
- ₹44.29 CrEBITDA · 16% margin
- ₹2.16 CrPaid-up capital
- 483Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Multani Pharmaceuticals Limited are on its company page.
Detailed financial statements for Multani Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Alternative Medicine Products
3 companies that operate in the same segment as Multani Pharmaceutical (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Homeopathic medicine manufacturing and online retail in India. | 1898 | Noida, Uttar Pradesh, India | USD 26.35 M | 1,192 | ||
Operates an online store specializing in ayurvedic and homeopathic medicines. | 2016 | Delhi, Delhi, India | USD 1.25 M | 16 | ||
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness. | 1992 | Faridabad, Haryana, India | USD 10.08 M | 570 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Multani Pharmaceutical
Multani Pharmaceutical was founded in 1983.
Multani Pharmaceutical is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Multani Pharmaceutical has 483 employees.
The primary company behind Multani Pharmaceutical, Multani Pharmaceuticals Limited, reported revenue of βΉ274 Cr for FY 2025, up 2% year on year.
Multani Pharmaceutical manufacturer of ayurvedic herbal medicines through providing healthcare solutions, alternative medicine products, alternative medicine products, and providing healthcare solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Multani Pharmaceutical offers Multani Pharmaceutical Platform.
Multani Pharmaceutical operates through Multani Pharmaceuticals Limited.
The legal entities of Multani Pharmaceutical currently have 5 directors, including Rajesh Sabharwal, Sanjay Kumar, Pradeep Multani and others.